Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-crystalline Megestrol Acetate for Cachexia in ES-SCLC
NCT06961201Phase 3Not yet recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- May 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in cancer cachexia, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Planned start May 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT06961201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06961201.